急诊冠状动脉内支架术后无复流现象的研究

被引：16

作者：

张毅 ^{[1
]}

陈熤 ^{[2
]}

李剑 ^{[3
]}

施海明 ^{[3
]}

机构：

[1] 浦城县新华医院内科

[2] 复旦大学附属华山医院中西医结合科

[3] 复旦大学附属华山医院心内科

来源：

国际心血管病杂志 | 2010年 / 37卷 / 05期

关键词：

无复流现象; 经皮冠状动脉介入术; 冠状动脉内支架术; 急性心肌梗死; 抗血小板治疗;

D O I：

暂无

中图分类号：

R542.22 [];

学科分类号：

摘要：

对于急性心肌梗死患者,以急诊冠状动脉内支架植入术为代表的血管重建治疗是主要的治疗方式,但部分患者在支架安置术后仍出现无复流现象,这其中的原因尚无定论。目前研究认为,无复流现象的成因可能与血栓导致的远端栓塞、炎症反应和氧化应激、血管内皮细胞缺血性损伤、冠状动脉介入操作诱发的血管痉挛收缩以及血管再灌注损伤有关,目前临床上常采用物理和药物两大类方法来防治无复流现象的发生。此文就近年来关于急诊冠脉支架术后发生无复流现象成因和治疗的相关研究进展作一综述。

引用

页码：286 / 288

页数：3

共 11 条

[1]

Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging [J].

Eitel, Ingo ;

Nowak, Marek ;

Stehl, Clemens ;

Adams, Volker ;

Fuernau, Georg ;

Hildebrand, Lysann ;

Desch, Steffen ;

Schuler, Gerhard ;

Thiele, Holger .

AMERICAN HEART JOURNAL, 2010, 159 (05) :882-890

[2]

Meta-analysis of the role of high-dose statins administered prior to percutaneous coronary intervention in reducing major adverse cardiac events in patients with coronary artery disease [J].

Hao, Pan-Pan ;

Chen, Yu-Guo ;

Wang, Jia-Li ;

Ji, Wen-Qing ;

Xue, Li ;

Liu, Xiang-Hong ;

Wang, Xing-Li ;

Zhang, Yun .

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (04) :496-500

[3]

Microvascular Obstruction after Percutaneous Coronary Intervention [J].

Lee, Chi-Hang ;

Tse, Hung-Fat .

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2010, 75 (03) :369-377

[4]

High-dose tirofiban with enoxaparin and inflammatory markers in high-risk percutaneous intervention [J].

Walters, D. L. ;

Ray, M. J. ;

Wood, P. ;

Perrin, E. J. ;

Bett, J. H. N. ;

Aroney, C. N. .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2010, 40 (02) :139-147

[5]

Cell swelling; impulse conduction; and cardiac arrhythmias in the failing heart. Opposite effects of angiotensin II and angiotensin (1–7) on cell volume regulation.[J].Walmor C. De Mello.Molecular and Cellular Biochemistry.2009, 1

[6]

Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation [J].

Horii, Manabu ;

Uemura, Shiro ;

Uemura, Masahito ;

Matsumoto, Masanori ;

Ishizashi, Hiromichi ;

Imagawa, Keiichi ;

Iwama, Hajime ;

Takeda, Yukiji ;

Kawata, Hiroyuki ;

Nakajima, Tamio ;

Fujimura, Yoshihiro ;

Saito, Yoshihiko .

HEART AND VESSELS, 2008, 23 (05) :301-307

[7]

Coronary microembolization [J].

Skyschally, Andreas ;

Leineweber, Kirsten ;

Gres, Petra ;

Haude, Michael ;

Erbel, Raimund ;

Heusch, Gerd .

BASIC RESEARCH IN CARDIOLOGY, 2006, 101 (05) :373-382

[8]

The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusion [J].

Reffelmann, Thorsten ;

Kloner, Robert A. .

BASIC RESEARCH IN CARDIOLOGY, 2006, 101 (05) :359-372

[9]

Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction [J].

Morishima, I ;

Sone, T ;

Okumura, K ;

Tsuboi, H ;

Kondo, J ;

Mukawa, H ;

Matsui, H ;

Toki, Y ;

Ito, T ;

Hayakawa, T .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (04) :1202-1209

[10]

Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit..Reffelmann T; Kloner RA;.American Journal of Physiology - Heart and Circulatory Physiology.2002, 03

← 1 2 →